N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells

Gelijkaardige items

• N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
  door: Contis-Montes de Oca, Arturo, et al.
  Gepubliceerd in: (2018)
• Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
  door: Contis-Montes de Oca, Arturo, et al.
  Gepubliceerd in: (2019)
• Study of acute lethality, teratogenesis, and metabolomic changes of N-(2’-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) on Artemia franciscana
  door: Cynthia Fernández-Pomares, et al.
  Gepubliceerd in: (2025-05-01)
• Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
  door: Sixto-López, Yudibeth, et al.
  Gepubliceerd in: (2020)
• Pharmacokinetics in Wistar Rats of 5-[(4-Carboxybutanoyl)Amino]-2-Hydroxybenzoic Acid: A Novel Synthetic Derivative of 5-Aminosalicylic Acid (5-ASA) with Possible Anti-Inflammatory Activity
  door: Romero-Castro, Aurelio, et al.
  Gepubliceerd in: (2016)